NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,593,000 | +2.9% | 367,113 | -1.7% | 0.36% | +9.1% |
| Q2 2021 | $6,407,000 | -18.9% | 373,368 | -5.5% | 0.33% | -23.4% |
| Q1 2021 | $7,899,000 | +9.4% | 394,929 | -7.0% | 0.43% | +0.2% |
| Q4 2020 | $7,217,000 | -8.8% | 424,504 | -11.0% | 0.43% | -19.5% |
| Q3 2020 | $7,914,000 | -30.8% | 477,004 | -3.4% | 0.53% | -35.6% |
| Q2 2020 | $11,431,000 | -5.3% | 493,586 | -27.0% | 0.83% | -15.5% |
| Q1 2020 | $12,075,000 | +109.4% | 676,496 | +153.2% | 0.98% | +145.9% |
| Q4 2019 | $5,766,000 | -15.4% | 267,130 | -28.6% | 0.40% | -19.7% |
| Q3 2019 | $6,819,000 | -13.0% | 374,355 | +69.9% | 0.50% | -10.3% |
| Q2 2019 | $7,838,000 | – | 220,290 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |